These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 16322310

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity.
    Errington F, Willmore E, Leontiou C, Tilby MJ, Austin CA.
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):155-62. PubMed ID: 14504921
    [Abstract] [Full Text] [Related]

  • 4. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
    Marchion DC, Bicaku E, Daud AI, Richon V, Sullivan DM, Munster PN.
    J Cell Biochem; 2004 May 15; 92(2):223-37. PubMed ID: 15108350
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Poisons of DNA topoisomerases I and II].
    Charcosset JY, Soues S, Laval F.
    Bull Cancer; 1993 Nov 15; 80(11):923-54. PubMed ID: 8081034
    [Abstract] [Full Text] [Related]

  • 9. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE, Cadena RS, Raimondi SC, Beck WT.
    Mol Pharmacol; 2000 Feb 15; 57(2):296-307. PubMed ID: 10648639
    [Abstract] [Full Text] [Related]

  • 10. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
    Liu T, Liu PY, Tee AE, Haber M, Norris MD, Gleave ME, Marshall GM.
    Eur J Cancer; 2009 Jul 15; 45(10):1846-54. PubMed ID: 19342222
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells.
    Hazlehurst LA, Argilagos RF, Emmons M, Boulware D, Beam CA, Sullivan DM, Dalton WS.
    Cancer Res; 2006 Feb 15; 66(4):2338-45. PubMed ID: 16489039
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytotoxic mechanism of XK469: resistance of topoisomerase IIbeta knockout cells and inhibition of topoisomerase I.
    Snapka RM, Gao H, Grabowski DR, Brill D, Chan KK, Li L, Li GC, Ganapathi R.
    Biochem Biophys Res Commun; 2001 Feb 02; 280(4):1155-60. PubMed ID: 11162648
    [Abstract] [Full Text] [Related]

  • 16. Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha.
    Herzog CE, Holmes KA, Tuschong LM, Ganapathi R, Zwelling LA.
    Cancer Res; 1998 Dec 01; 58(23):5298-300. PubMed ID: 9850052
    [Abstract] [Full Text] [Related]

  • 17. Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrine.
    Sorensen M, Sehested M, Jensen PB.
    Mol Pharmacol; 1999 Mar 01; 55(3):424-31. PubMed ID: 10051525
    [Abstract] [Full Text] [Related]

  • 18. HDAC inhibitors, MS275 and SBHA, enhances cytotoxicity induced by oxaliplatin in the colorectal cancer cell lines.
    Flis S, Gnyszka A, Spławiński J.
    Biochem Biophys Res Commun; 2009 Sep 18; 387(2):336-41. PubMed ID: 19596269
    [Abstract] [Full Text] [Related]

  • 19. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D.
    Int J Oncol; 2007 Sep 18; 31(3):633-41. PubMed ID: 17671692
    [Abstract] [Full Text] [Related]

  • 20. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ, Reynolds CP.
    J Natl Cancer Inst; 2007 Jul 18; 99(14):1107-19. PubMed ID: 17623797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.